Susquehanna International Group
BPMC

Susquehanna International Group’s Blueprint Medicines BPMC Stock Holding History

Susquehanna International Group’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-457,300
Closed -$58.6M – 12439
2025
Q2 		$58.6M Buy
457,300
+250,700
+121% +$26M 0.01% 1062
2025
Q1 		$18.3M Sell
206,600
-50,400
-20% -$4.92M ﹤0.01% 1827
2024
Q4 		$22.4M Sell
257,000
-103,700
-29% -$9.5M ﹤0.01% 1762
2024
Q3 		$33.4M Buy
360,700
+6,300
+2% +$626K 0.01% 1387
2024
Q2 		$38.2M Buy
354,400
+25,700
+8% +$2.57M 0.01% 1175
2024
Q1 		$31.2M Buy
328,700
+106,600
+48% +$9.14M 0.01% 1374
2023
Q4 		$20.5M Sell
222,100
-49,200
-18% -$3.19M ﹤0.01% 1790
2023
Q3 		$13.6M Buy
271,300
+25,700
+10% +$1.37M ﹤0.01% 2184
2023
Q2 		$15.5M Buy
245,600
+24,800
+11% +$1.35M ﹤0.01% 1989
2023
Q1 		$9.93M Buy
220,800
+91,900
+71% +$4.14M ﹤0.01% 2465
2022
Q4 		$5.65M Buy
128,900
+61,400
+91% +$2.94M ﹤0.01% 3056
2022
Q3 		$4.45M Buy
67,500
+31,000
+85% +$1.99M ﹤0.01% 3360
2022
Q2 		$1.84M Sell
36,500
-6,800
-16% -$398K ﹤0.01% 5088
2022
Q1 		$2.77M Buy
43,300
+7,300
+20% +$524K ﹤0.01% 4775
2021
Q4 		$3.86M Sell
36,000
-38,000
-51% -$3.97M ﹤0.01% 4194
2021
Q3 		$7.61M Sell
74,000
-8,700
-11% -$810K ﹤0.01% 3275
2021
Q2 		$7.27M Buy
82,700
+49,200
+147% +$4.51M ﹤0.01% 3379
2021
Q1 		$3.26M Sell
33,500
-136,600
-80% -$13.6M ﹤0.01% 4779
2020
Q4 		$19.1M Buy
170,100
+63,900
+60% +$6.73M ﹤0.01% 1792
2020
Q3 		$9.85M Sell
106,200
-60,100
-36% -$4.63M ﹤0.01% 2194
2020
Q2 		$13M Sell
166,300
-66,400
-29% -$4.49M ﹤0.01% 1858
2020
Q1 		$13.6M Buy
232,700
+102,700
+79% +$6.61M ﹤0.01% 1458
2019
Q4 		$10.4M Buy
130,000
+39,400
+43% +$2.95M ﹤0.01% 2040
2019
Q3 		$6.66M Buy
90,600
+29,600
+49% +$2.56M ﹤0.01% 2384
2019
Q2 		$5.75M Sell
61,000
-11,000
-15% -$908K ﹤0.01% 2530
2019
Q1 		$5.76M Buy
72,000
+38,100
+112% +$2.82M ﹤0.01% 2304
2018
Q4 		$1.83M Sell
33,900
-67,700
-67% -$4.11M ﹤0.01% 3655
2018
Q3 		$7.93M Sell
101,600
-79,700
-44% -$5.54M ﹤0.01% 2162
2018
Q2 		$11.5M Buy
181,300
+94,100
+108% +$7.49M ﹤0.01% 1797
2018
Q1 		$8M Buy
87,200
+65,700
+306% +$5.66M ﹤0.01% 2013
2017
Q4 		$1.62M Sell
21,500
-1,000
-4% -$70.4K ﹤0.01% 4307
2017
Q3 		$1.57M Buy
22,500
+2,400
+12% +$128K ﹤0.01% 4365
2017
Q2 		$1.02M Sell
20,100
-12,300
-38% -$522K ﹤0.01% 5222
2017
Q1 		$1.3M Buy
32,400
+19,700
+155% +$705K ﹤0.01% 4584
2016
Q4 		$356K Buy
12,700
+3,400
+37% +$102K ﹤0.01% 7638
2016
Q3 		$276K Buy
+9,300
New +$231K ﹤0.01% 7065

Other funds holding BPMC

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Susquehanna International Group's BPMC Position: Q3 2025 in Review

Susquehanna International Group sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 184,115 shares — an estimated $23.6M sold.

Susquehanna International Group first reported a position in BPMC in Q4 2017 and held it in 28 quarters. The position peaked at $36.5M in Q1 2025. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.

  • Susquehanna International Group reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
  • Susquehanna International Group sold 184,115 Blueprint Medicines shares in Q3 2025, an estimated $23.6M.
  • Susquehanna International Group first reported a position in Blueprint Medicines in Q4 2017 and held it in 28 quarters.
  • Susquehanna International Group's Blueprint Medicines position peaked at $36.5M in Q1 2025.
  • 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.

Based on Susquehanna International Group's 13F filing for Q3 2025, filed 14 Nov 2025.